for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

PYC Therapeutics Ltd

PYC.AX

Latest Trade

0.13AUD

Change

0.01(+4.00%)

Volume

949,572

Today's Range

0.12

 - 

0.13

52 Week Range

0.02

 - 

0.14

As of on the Australian Stock Exchange Ltd ∙ Minimum 15 minute delay

Pricing

Previous Close
0.13
Open
0.12
Volume
949,572
3M AVG Volume
50.13
Today's High
0.13
Today's Low
0.12
52 Week High
0.14
52 Week Low
0.02
Shares Out (MIL)
2,931.43
Market Cap (MIL)
366.43
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

更多

Phylogica Posts HY Net Loss Attributable $2.1 Mln Vs Loss Of $946,000

Pyc Therapeutics Ltd Appoints Doug Huey As CEO And Board Director

PYC Therapeutics Updates On Investigational New Drug-Enabling Studies For Lead Drug Molecule

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About PYC Therapeutics Ltd

PYC Therapeutics Limited, formerly Phylogica Limited, is a pharmaceutical company. The Company is engaged combining its cell-penetrating peptides (CPP) technology with in ASOs to create a pipeline of drugs called CPP-ASOs. The Company intends to expand its pipeline to include other disease indications and therapeutic areas such as genetic neurodegenerative and liver diseases. Its pipeline products is Ocular, which is focused on treating retinitis pigmentosa and inherited retinal disease.

Industry

Biotechnology & Drugs

Contact Info

Harry Perkins Institute, 6 Verdun St

NEDLANDS, WAS

6009

Australia

+61.8.61510992

https://pyctx.com/

Executive Leadership

Alan Tribe

Chairperson of the Board

Douglas Huey

Chief Executive Officer

Kevin R. Hart

Chief Financial Officer, Company Secretary

Rohan Hockings

Director, Chief Strategy Officer

May Orfali

Chief Medical Officer

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
11.46
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
2.72
LT Debt To Equity (MRQ)
2.26
Return on Investment (TTM)
-25.24
Return on Equity (TTM)
-22.62

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up